series-a
Stage
About
Critical Pressure is a biopharmaceutical company developing drugs to treat vascular dysfunction and shock, with an initial focus on severe sepsis, using technology that aims to avoid harmful effects associated with excess fluid administration.
Explore Critical Pressure's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.